25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

IMM (Immutep) Stock Analysis
Buy, Hold or Sell?

Let's analyze Immutep together

I guess you are interested in Immutep Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Immutep’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Immutep’s Price Targets

I'm going to help you getting a better view of Immutep Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Immutep Ltd

I send you an email if I find something interesting about Immutep Ltd.

1. Quick Overview

1.1. Quick analysis of Immutep (30 sec.)










1.2. What can you expect buying and holding a share of Immutep? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.13
Expected worth in 1 year
A$0.28
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
A$0.15
Return On Investment
47.0%

For what price can you sell your share?

Current Price per Share
A$0.31
Expected price per share
A$0.27 - A$0.31
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Immutep (5 min.)




Live pricePrice per Share (EOD)
A$0.31
Intrinsic Value Per Share
A$-0.32 - A$-0.17
Total Value Per Share
A$-0.19 - A$-0.04

2.2. Growth of Immutep (5 min.)




Is Immutep growing?

Current yearPrevious yearGrowGrow %
How rich?$118.8m$85.6m$33.2m28.0%

How much money is Immutep making?

Current yearPrevious yearGrowGrow %
Making money-$26.7m-$25m-$1.7m-6.6%
Net Profit Margin0.0%-1,138.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Immutep (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#329 / 916

Most Revenue
#803 / 916

Most Profit
#703 / 916

Most Efficient
#308 / 916
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Immutep?

Welcome investor! Immutep's management wants to use your money to grow the business. In return you get a share of Immutep.

First you should know what it really means to hold a share of Immutep. And how you can make/lose money.

Speculation

The Price per Share of Immutep is A$0.31. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Immutep.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Immutep, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.13. Based on the TTM, the Book Value Change Per Share is A$0.04 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Immutep.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.02-5.9%-0.02-5.9%-0.02-5.5%-0.01-4.4%-0.01-4.1%
Usd Book Value Change Per Share0.027.4%0.027.4%0.025.9%0.014.6%0.012.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.027.4%0.027.4%0.025.9%0.014.6%0.012.3%
Usd Price Per Share0.19-0.19-0.20-0.20-0.11-
Price to Earnings Ratio-10.05--10.05--11.49--15.63--9.19-
Price-to-Total Gains Ratio8.09-8.09-10.82-16.91-13.18-
Price to Book Ratio2.27-2.27-3.36-5.56-3.76-
Price-to-Total Gains Ratio8.09-8.09-10.82-16.91-13.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.194463
Number of shares5142
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.020.01
Usd Total Gains Per Share0.020.01
Gains per Quarter (5142 shares)117.5673.19
Gains per Year (5142 shares)470.25292.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104704600293283
209419300585576
30141114000878869
4018811870011711162
5023512340014641455
6028222810017561748
7032923280020492041
8037623750023422334
9042324220026352627
10047034690029272920

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.017.08.00.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.02.00.080.0%15.010.00.060.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.025.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.02.00.080.0%15.010.00.060.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Immutep Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0360.0360%0.029+25%0.023+61%0.011+218%
Book Value Per Share--0.1300.1300%0.094+39%0.072+80%0.046+182%
Current Ratio--18.24818.2480%13.811+32%13.658+34%10.277+78%
Debt To Asset Ratio--0.0600.0600%0.074-20%0.121-51%0.191-69%
Debt To Equity Ratio--0.0640.0640%0.080-21%0.150-58%0.259-75%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--417341515.720417341515.7200%570948970.040-27%514579781.136-19%287502264.269+45%
Eps---0.029-0.0290%-0.027-7%-0.022-26%-0.020-31%
Ev To Ebitda Ratio--infinfnan%-13.317nan%infnan%infnan%
Ev To Sales Ratio--infinfnan%162.862+inf%infnan%infnan%
Free Cash Flow Per Share---0.025-0.0250%-0.025+0%-0.018-27%-0.012-51%
Free Cash Flow To Equity Per Share--0.0410.0410%0.028+48%0.023+81%0.012+249%
Gross Profit Margin--1.0001.0000%1.135-12%1.027-3%1.014-1%
Intrinsic Value_10Y_max---0.168--------
Intrinsic Value_10Y_min---0.325--------
Intrinsic Value_1Y_max---0.013--------
Intrinsic Value_1Y_min---0.026--------
Intrinsic Value_3Y_max---0.042--------
Intrinsic Value_3Y_min---0.084--------
Intrinsic Value_5Y_max---0.074--------
Intrinsic Value_5Y_min---0.149--------
Market Cap451232904.960+5%429399054.720429399054.7200%458510855.040-6%467244395.136-8%261001845.769+65%
Net Profit Margin----0%-11.3800%-41.9970%-70.4930%
Operating Margin----0%-12.8180%-43.8440%-73.7890%
Operating Ratio----0%12.818-100%47.236-100%91.030-100%
Pb Ratio2.381+5%2.2662.2660%3.360-33%5.563-59%3.760-40%
Pe Ratio-10.563-5%-10.052-10.0520%-11.493+14%-15.635+56%-9.187-9%
Price Per Share0.310+5%0.2950.2950%0.315-6%0.321-8%0.179+65%
Price To Free Cash Flow Ratio-12.621-5%-12.010-12.0100%-12.761+6%-20.969+75%-202.605+1587%
Price To Total Gains Ratio8.505+5%8.0948.0940%10.816-25%16.909-52%13.178-39%
Quick Ratio--1.9161.9160%13.445-86%10.075-81%8.288-77%
Return On Assets---0.212-0.2120%-0.271+28%-0.290+37%-0.489+131%
Return On Equity---0.225-0.2250%-0.292+30%-0.335+48%-0.613+172%
Total Gains Per Share--0.0360.0360%0.029+25%0.023+61%0.011+218%
Usd Book Value--118886988.757118886988.7570%85607247.720+39%66072185.773+80%42097391.516+182%
Usd Book Value Change Per Share--0.0230.0230%0.018+25%0.014+61%0.007+218%
Usd Book Value Per Share--0.0820.0820%0.059+39%0.045+80%0.029+182%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--261798332.811261798332.8110%358156288.906-27%322795896.707-19%180350170.376+45%
Usd Eps---0.018-0.0180%-0.017-7%-0.014-26%-0.013-31%
Usd Free Cash Flow---22428232.025-22428232.0250%-22538889.000+0%-16366369.161-27%-10882918.299-51%
Usd Free Cash Flow Per Share---0.015-0.0150%-0.015+0%-0.011-27%-0.007-51%
Usd Free Cash Flow To Equity Per Share--0.0260.0260%0.017+48%0.014+81%0.007+249%
Usd Market Cap283058401.281+5%269362027.026269362027.0260%287623859.367-6%293102409.069-8%163726457.851+65%
Usd Price Per Share0.194+5%0.1850.1850%0.198-6%0.201-8%0.112+65%
Usd Profit---26796138.863-26796138.8630%-25026979.100-7%-19847101.416-26%-18238459.067-32%
Usd Revenue----0%2199139.411-100%1885079.282-100%1503083.065-100%
Usd Total Gains Per Share--0.0230.0230%0.018+25%0.014+61%0.007+218%
 EOD+6 -2MRQTTM+0 -0YOY+21 -145Y+17 -1710Y+22 -12

3.3 Fundamental Score

Let's check the fundamental score of Immutep Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.563
Price to Book Ratio (EOD)Between0-12.381
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.916
Current Ratio (MRQ)Greater than118.248
Debt to Asset Ratio (MRQ)Less than10.060
Debt to Equity Ratio (MRQ)Less than10.064
Return on Equity (MRQ)Greater than0.15-0.225
Return on Assets (MRQ)Greater than0.05-0.212
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Immutep Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.459
Ma 20Greater thanMa 500.295
Ma 50Greater thanMa 1000.314
Ma 100Greater thanMa 2000.319
OpenGreater thanClose0.300
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Immutep Ltd

Immutep Limited, a late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alpha (efti or IMP321), a soluble LAG-3lg fusion based, which is in clinical development for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. In addition, it develops INSIGHT-003, which is in phase I to treat 1L NSCLC and solid tumors; INSIGHT-005, which is in phase I to treat metastatic urothelial cancer; IMP761, which is in preclinical trial to treat autoimmune disease; and IMP731 and IMP701 which is in clinical development. Further, the company develops LAG525, which is in phase II clinical trial to treat solid tumors and blood cancer, triple negative breast cancer, and melanoma; and in phase I to treat triple negative breast cancer. Immutep has collaboration with Merck & Co., Inc., GlaxoSmithKline, EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.

Fundamental data was last updated by Penke on 2025-03-10 11:34:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Immutep earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Immutep to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Immutep Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,138.0%+1,138.0%
TTM-5Y-4,199.7%+4,199.7%
5Y-4,199.7%10Y-7,049.3%+2,849.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--90.0%+90.0%
TTM--190.2%+190.2%
YOY-1,138.0%-200.7%-937.3%
5Y-4,199.7%-336.0%-3,863.7%
10Y-7,049.3%-488.5%-6,560.8%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Immutep is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Immutep to theΒ Biotechnology industry mean.
  • -21.2% Return on Assets means thatΒ Immutep generatedΒ $-0.21 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Immutep Ltd:

  • The MRQ is -21.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -21.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.2%TTM-21.2%0.0%
TTM-21.2%YOY-27.1%+5.9%
TTM-21.2%5Y-29.0%+7.8%
5Y-29.0%10Y-48.9%+19.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.2%-11.9%-9.3%
TTM-21.2%-11.9%-9.3%
YOY-27.1%-11.6%-15.5%
5Y-29.0%-12.7%-16.3%
10Y-48.9%-14.3%-34.6%
4.3.1.3. Return on Equity

Shows how efficient Immutep is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Immutep to theΒ Biotechnology industry mean.
  • -22.5% Return on Equity means Immutep generated $-0.23Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Immutep Ltd:

  • The MRQ is -22.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -22.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.5%TTM-22.5%0.0%
TTM-22.5%YOY-29.2%+6.7%
TTM-22.5%5Y-33.5%+10.9%
5Y-33.5%10Y-61.3%+27.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.5%-15.5%-7.0%
TTM-22.5%-15.8%-6.7%
YOY-29.2%-14.6%-14.6%
5Y-33.5%-18.0%-15.5%
10Y-61.3%-19.2%-42.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Immutep Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Immutep is operatingΒ .

  • Measures how much profit Immutep makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Immutep to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Immutep Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,281.8%+1,281.8%
TTM-5Y-4,384.4%+4,384.4%
5Y-4,384.4%10Y-7,378.9%+2,994.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--186.4%+186.4%
TTM--308.8%+308.8%
YOY-1,281.8%-206.9%-1,074.9%
5Y-4,384.4%-368.2%-4,016.2%
10Y-7,378.9%-475.9%-6,903.0%
4.3.2.2. Operating Ratio

Measures how efficient Immutep is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Immutep Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY12.818-12.818
TTM-5Y47.236-47.236
5Y47.23610Y91.030-43.794
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.024-2.024
TTM-3.198-3.198
YOY12.8182.999+9.819
5Y47.2364.695+42.541
10Y91.0306.513+84.517
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Immutep Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Immutep is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 18.25Β means the company has $18.25 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Immutep Ltd:

  • The MRQ is 18.248. The company is very able to pay all its short-term debts. +2
  • The TTM is 18.248. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ18.248TTM18.2480.000
TTM18.248YOY13.811+4.436
TTM18.2485Y13.658+4.590
5Y13.65810Y10.277+3.381
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ18.2483.635+14.613
TTM18.2483.879+14.369
YOY13.8114.496+9.315
5Y13.6585.950+7.708
10Y10.2776.223+4.054
4.4.3.2. Quick Ratio

Measures if Immutep is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Immutep to theΒ Biotechnology industry mean.
  • A Quick Ratio of 1.92Β means the company can pay off $1.92 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Immutep Ltd:

  • The MRQ is 1.916. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.916. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.916TTM1.9160.000
TTM1.916YOY13.445-11.530
TTM1.9165Y10.075-8.159
5Y10.07510Y8.288+1.787
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9163.055-1.139
TTM1.9163.336-1.420
YOY13.4454.265+9.180
5Y10.0755.921+4.154
10Y8.2886.474+1.814
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Immutep Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of ImmutepΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Immutep to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.06Β means that Immutep assets areΒ financed with 6.0% credit (debt) and the remaining percentage (100% - 6.0%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Immutep Ltd:

  • The MRQ is 0.060. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.060. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.060TTM0.0600.000
TTM0.060YOY0.074-0.015
TTM0.0605Y0.121-0.061
5Y0.12110Y0.191-0.069
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0600.338-0.278
TTM0.0600.340-0.280
YOY0.0740.312-0.238
5Y0.1210.359-0.238
10Y0.1910.382-0.191
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Immutep is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Immutep to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 6.4% means that company has $0.06 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Immutep Ltd:

  • The MRQ is 0.064. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.064. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.064TTM0.0640.000
TTM0.064YOY0.080-0.017
TTM0.0645Y0.150-0.086
5Y0.15010Y0.259-0.109
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0640.393-0.329
TTM0.0640.427-0.363
YOY0.0800.396-0.316
5Y0.1500.453-0.303
10Y0.2590.494-0.235
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Immutep generates.

  • Above 15 is considered overpriced butΒ always compareΒ Immutep to theΒ Biotechnology industry mean.
  • A PE ratio of -10.05 means the investor is paying $-10.05Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Immutep Ltd:

  • The EOD is -10.563. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.052. Based on the earnings, the company is expensive. -2
  • The TTM is -10.052. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.563MRQ-10.052-0.511
MRQ-10.052TTM-10.0520.000
TTM-10.052YOY-11.493+1.440
TTM-10.0525Y-15.635+5.583
5Y-15.63510Y-9.187-6.448
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.563-2.050-8.513
MRQ-10.052-2.500-7.552
TTM-10.052-3.216-6.836
YOY-11.493-3.354-8.139
5Y-15.635-6.197-9.438
10Y-9.187-6.955-2.232
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Immutep Ltd:

  • The EOD is -12.621. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -12.010. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.010. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.621MRQ-12.010-0.611
MRQ-12.010TTM-12.0100.000
TTM-12.010YOY-12.761+0.751
TTM-12.0105Y-20.969+8.959
5Y-20.96910Y-202.605+181.636
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-12.621-2.824-9.797
MRQ-12.010-3.507-8.503
TTM-12.010-3.859-8.151
YOY-12.761-4.336-8.425
5Y-20.969-8.240-12.729
10Y-202.605-9.233-193.372
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Immutep is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 2.27 means the investor is paying $2.27Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Immutep Ltd:

  • The EOD is 2.381. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.266. Based on the equity, the company is underpriced. +1
  • The TTM is 2.266. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.381MRQ2.266+0.115
MRQ2.266TTM2.2660.000
TTM2.266YOY3.360-1.094
TTM2.2665Y5.563-3.297
5Y5.56310Y3.760+1.803
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.3811.906+0.475
MRQ2.2662.136+0.130
TTM2.2662.391-0.125
YOY3.3602.453+0.907
5Y5.5633.811+1.752
10Y3.7604.584-0.824
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Immutep Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets201,579
Total Liabilities12,058
Total Stockholder Equity189,522
 As reported
Total Liabilities 12,058
Total Stockholder Equity+ 189,522
Total Assets = 201,579

Assets

Total Assets201,579
Total Current Assets191,350
Long-term Assets10,229
Total Current Assets
Cash And Cash Equivalents 161,790
Short-term Investments 20,086
Net Receivables 5
Total Current Assets  (as reported)191,350
Total Current Assets  (calculated)181,882
+/- 9,469
Long-term Assets
Property Plant Equipment 680
Goodwill 110
Intangible Assets 8,131
Long-term Assets  (as reported)10,229
Long-term Assets  (calculated)8,921
+/- 1,308

Liabilities & Shareholders' Equity

Total Current Liabilities10,486
Long-term Liabilities1,571
Total Stockholder Equity189,522
Total Current Liabilities
Accounts payable 3,790
Total Current Liabilities  (as reported)10,486
Total Current Liabilities  (calculated)3,790
+/- 6,696
Long-term Liabilities
Long term Debt 961
Capital Lease Obligations Min Short Term Debt633
Long-term Liabilities  (as reported)1,571
Long-term Liabilities  (calculated)1,594
+/- 23
Total Stockholder Equity
Total Stockholder Equity (as reported)189,522
Total Stockholder Equity (calculated)0
+/- 189,522
Other
Capital Stock542,105
Common Stock Shares Outstanding 1,452,612
Net Invested Capital 190,483
Net Working Capital 180,864
Property Plant and Equipment Gross 1,372



5.2. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-30
> Total Assets 
2,095
4,244
5,926
3,968
5,768
9,131
7,360
4,358
2,821
2,490
19,011
57,641
41,613
32,814
25,378
30,983
42,554
34,964
46,999
40,541
46,597
82,031
102,170
147,449
201,579
201,579147,449102,17082,03146,59740,54146,99934,96442,55430,98325,37832,81441,61357,64119,0112,4902,8214,3587,3609,1315,7683,9685,9264,2442,095
   > Total Current Assets 
0
0
0
0
0
0
0
0
1,181
1,373
16,774
57,063
40,903
31,808
24,684
8,023
21,671
15,919
28,643
23,542
31,152
68,419
90,812
134,965
191,350
191,350134,96590,81268,41931,15223,54228,64315,91921,6718,02324,68431,80840,90357,06316,7741,3731,18100000000
       Cash And Cash Equivalents 
687
2,992
3,715
1,579
2,785
7,533
3,211
672
1,109
951
15,641
45,931
17,005
22,023
14,200
6,760
20,880
12,237
23,476
16,568
26,322
60,128
79,995
123,418
161,790
161,790123,41879,99560,12826,32216,56823,47612,23720,8806,76014,20022,02317,00545,93115,6419511,1096723,2117,5332,7851,5793,7152,992687
       Short-term Investments 
0
50
0
0
0
0
0
0
0
0
10,000
10,000
21,045
8,000
9,000
0
0
0
0
0
0
0
0
0
20,086
20,0860000000009,0008,00021,04510,00010,00000000000500
       Net Receivables 
118
149
34
66
603
77
112
33
71
357
428
420
793
357
362
319
169
2,194
3,482
5,231
3,392
6,124
8,374
7,973
5
57,9738,3746,1243,3925,2313,4822,1941693193623577934204283577133112776036634149118
       Inventory 
0
0
0
0
0
0
0
0
-23
66
0
214
192
0
1,091
402
592
642
0
0
0
465
-1,108
0
0
00-1,1084650006425924021,0910192214066-2300000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
1,640
1,116
2,237
578
710
1,006
694
22,960
20,883
19,045
18,356
17,000
15,445
13,611
11,358
12,484
10,229
10,22912,48411,35813,61115,44517,00018,35619,04520,88322,9606941,0067105782,2371,1161,64000000000
       Property Plant Equipment 
1,265
9
63
67
61
47
51
47
30
19
97
120
484
835
577
298
32
24
26
53
251
310
308
469
680
6804693083102515326243229857783548412097193047514761676391,265
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
110
110
110
110
110
110
110
110
110
110
110110110110110110110110110110000000000000000
       Intangible Assets 
0
1,044
2,055
2,256
2,299
1,266
668
626
584
542
500
458
226
171
117
22,552
20,742
18,910
18,219
16,837
15,085
12,737
10,444
9,380
8,131
8,1319,38010,44412,73715,08516,83718,21918,91020,74222,5521171712264585005425846266681,2662,2992,2562,0551,0440
       Other Assets 
0
0
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
454
496
2,525
0
02,5254964540000000000000000005000
> Total Liabilities 
219
102
466
875
641
788
1,043
278
188
677
2,224
2,542
4,455
3,566
2,786
6,294
7,237
8,431
13,477
16,154
13,298
8,759
8,092
10,980
12,058
12,05810,9808,0928,75913,29816,15413,4778,4317,2376,2942,7863,5664,4552,5422,2246771882781,043788641875466102219
   > Total Current Liabilities 
189
101
466
873
638
775
1,026
261
188
677
2,223
2,537
4,444
3,560
2,771
4,380
1,472
2,632
3,853
5,299
3,364
5,340
6,414
9,772
10,486
10,4869,7726,4145,3403,3645,2993,8532,6321,4724,3802,7713,5604,4442,5372,2236771882611,026775638873466101189
       Short-term Debt 
0
0
0
0
0
0
0
0
0
240
700
10,000
21,045
8,000
9,000
1,508
0
5,779
6,646
0
129
208
173
185
0
018517320812906,6465,77901,5089,0008,00021,04510,000700240000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,508
0
5,779
6,646
0
0
0
0
0
0
0000006,6465,77901,508000000000000000
       Accounts payable 
164
0
466
191
288
378
409
122
119
116
1,352
1,770
2,724
3,087
2,217
2,202
561
1,139
1,615
2,557
1,640
1,825
2,866
5,448
3,790
3,7905,4482,8661,8251,6402,5571,6151,1395612,2022,2173,0872,7241,7701,3521161191224093782881914660164
       Other Current Liabilities 
25
101
0
682
349
396
617
139
-50
205
-1,182
-1,003
-1,004
-2,642
-1,680
-1,786
911
1,493
2,238
2,742
-44
1,482
509
-1,310
0
0-1,3105091,482-442,7422,2381,493911-1,786-1,680-2,642-1,004-1,003-1,182205-50139617396349682010125
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
1
4
10
6
15
1,914
5,765
5,799
9,623
10,855
9,934
3,419
1,678
1,207
1,571
1,5711,2071,6783,4199,93410,8559,6235,7995,7651,91415610410000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,027
5,779
6,646
7,643
8,922
2,607
1,560
1,043
0
01,0431,5602,6078,9227,6436,6465,7795,0270000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
-240
-700
-10,000
-21,045
-8,000
-9,000
-1,508
0
-5,779
-6,646
0
133
80
235
208
633
633208235801330-6,646-5,7790-1,508-9,000-8,000-21,045-10,000-700-240000000000
> Total Stockholder Equity
1,876
3,131
4,337
3,093
5,066
8,343
6,316
4,080
2,633
1,813
16,788
55,099
37,158
29,248
22,592
24,690
35,318
26,532
33,522
24,388
33,299
73,272
94,077
136,469
189,522
189,522136,46994,07773,27233,29924,38833,52226,53235,31824,69022,59229,24837,15855,09916,7881,8132,6334,0806,3168,3435,0663,0934,3373,1311,876
   Retained Earnings -382,647-339,931-302,335-274,642-275,706-262,238-244,585-231,839-222,472-160,456-128,305-114,961-99,736-79,795-50,957-38,798-35,85200000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
-1,955
-1,955
-8
-1
181
1,883
1,883
5,268
63,258
63,019
64,874
65,534
66,015
34,492
29,005
30,128
0
030,12829,00534,49266,01565,53464,87463,01963,2585,2681,8831,883181-1-8-1,955-1,95500000000
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000



5.3. Balance Sheets

Currency in AUD. All numbers in thousands.




5.4. Cash Flows

Currency in AUD. All numbers in thousands.




5.5. Income Statements

Currency in AUD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-46,557
Operating Income-46,557-46,557
 
Operating Expense (+$)
Research Development41,547
Selling General Administrative8,853
Selling And Marketing Expenses0
Operating Expense46,55750,399
 
Net Interest Income (+$)
Interest Income3,883
Interest Expense-31
Other Finance Cost-0
Net Interest Income3,852
 
Pretax Income (+$)
Operating Income-46,557
Net Interest Income3,852
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-42,717-46,546
EBIT - interestExpense = -31
-42,717
-42,686
Interest Expense31
Earnings Before Interest and Taxes (EBIT)0-42,686
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-42,717
Tax Provision-0
Net Income From Continuing Ops-42,717-42,717
Net Income-42,717
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-11-3,852
 

Technical Analysis of Immutep
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Immutep. The general trend of Immutep is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Immutep's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Immutep Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Immutep Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.3 < 0.31 < 0.31.

The bearish price targets are: 0.2725 > 0.27 > 0.27.

Tweet this
Immutep Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Immutep Ltd. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Immutep Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Immutep Ltd. The current macd is -0.00476921.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Immutep price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Immutep. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Immutep price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Immutep Ltd Daily Moving Average Convergence/Divergence (MACD) ChartImmutep Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Immutep Ltd. The current adx is 18.47.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Immutep shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Immutep Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Immutep Ltd. The current sar is 0.27443107.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Immutep Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Immutep Ltd. The current rsi is 54.46. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Immutep Ltd Daily Relative Strength Index (RSI) ChartImmutep Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Immutep Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Immutep price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Immutep Ltd Daily Stochastic Oscillator ChartImmutep Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Immutep Ltd. The current cci is 86.29.

Immutep Ltd Daily Commodity Channel Index (CCI) ChartImmutep Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Immutep Ltd. The current cmo is 23.32.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Immutep Ltd Daily Chande Momentum Oscillator (CMO) ChartImmutep Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Immutep Ltd. The current willr is -14.14141414.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Immutep Ltd Daily Williams %R ChartImmutep Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Immutep Ltd.

Immutep Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Immutep Ltd. The current atr is 0.01424073.

Immutep Ltd Daily Average True Range (ATR) ChartImmutep Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Immutep Ltd. The current obv is -29,165,358.

Immutep Ltd Daily On-Balance Volume (OBV) ChartImmutep Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Immutep Ltd. The current mfi is 25.39.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Immutep Ltd Daily Money Flow Index (MFI) ChartImmutep Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Immutep Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-01-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Immutep Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Immutep Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.459
Ma 20Greater thanMa 500.295
Ma 50Greater thanMa 1000.314
Ma 100Greater thanMa 2000.319
OpenGreater thanClose0.300
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Immutep with someone you think should read this too:
  • Are you bullish or bearish on Immutep? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Immutep? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Immutep Ltd

I send you an email if I find something interesting about Immutep Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Immutep Ltd.

Receive notifications about Immutep Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.